225 related articles for article (PubMed ID: 19996403)
1. Use of genetics in the clinical evaluation of cardiomyopathy.
Judge DP
JAMA; 2009 Dec; 302(22):2471-6. PubMed ID: 19996403
[TBL] [Abstract][Full Text] [Related]
2. Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Hershberger RE; Cowan J; Morales A; Siegfried JD
Circ Heart Fail; 2009 May; 2(3):253-61. PubMed ID: 19808347
[TBL] [Abstract][Full Text] [Related]
3. A frameshift deletion mutation in the cardiac myosin-binding protein C gene associated with dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.
Hitomi N; Kubo T; Kitaoka H; Hirota T; Hamada T; Hoshikawa E; Hayato K; Okawa M; Kimura A; Doi YL
J Cardiol; 2010 Sep; 56(2):189-96. PubMed ID: 20605413
[TBL] [Abstract][Full Text] [Related]
4. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.
Maron BJ; Maron MS; Semsarian C
J Am Coll Cardiol; 2012 Aug; 60(8):705-15. PubMed ID: 22796258
[TBL] [Abstract][Full Text] [Related]
5. Genetic evaluation of familial cardiomyopathy.
Judge DP; Johnson NM
J Cardiovasc Transl Res; 2008 Jun; 1(2):144-54. PubMed ID: 20559909
[TBL] [Abstract][Full Text] [Related]
6. Microsatellite marker analysis in the treatment and diagnosis of familial hypertrophic cardiomyopathy.
Smolik S; Domal-Kwiatkowska D; Kapral M; Weglarz L
Acta Pol Pharm; 2010; 67(6):669-72. PubMed ID: 21229884
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes.
Kaski JP; Syrris P; Burch M; Tomé-Esteban MT; Fenton M; Christiansen M; Andersen PS; Sebire N; Ashworth M; Deanfield JE; McKenna WJ; Elliott PM
Heart; 2008 Nov; 94(11):1478-84. PubMed ID: 18467357
[TBL] [Abstract][Full Text] [Related]
8. Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression.
Keren A; Syrris P; McKenna WJ
Nat Clin Pract Cardiovasc Med; 2008 Mar; 5(3):158-68. PubMed ID: 18227814
[TBL] [Abstract][Full Text] [Related]
9. Dilated cardiomyopathy caused by a novel TNNT2 mutation-added value of genetic testing in the correct identification of affected subjects.
Van Acker H; De Sutter J; Vandekerckhove K; de Ravel TJ; Verhaaren H; De Backer J
Int J Cardiol; 2010 Oct; 144(2):307-9. PubMed ID: 19324435
[TBL] [Abstract][Full Text] [Related]
10. Familial dilated cardiomyopathy with troponin T K210del mutation.
Martins E; Silva-Cardoso J; Alves C; Pereira H; Soares B; Damasceno A; Abreu-Lima C; Amorim A; Rocha-Gonçalves F
Rev Port Cardiol; 2006 Mar; 25(3):295-300. PubMed ID: 16789403
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
[TBL] [Abstract][Full Text] [Related]
12. Cardiac troponin T lysine 210 deletion in a family with dilated cardiomyopathy.
Hanson EL; Jakobs PM; Keegan H; Coates K; Bousman S; Dienel NH; Litt M; Hershberger RE
J Card Fail; 2002 Feb; 8(1):28-32. PubMed ID: 11862580
[TBL] [Abstract][Full Text] [Related]
13. Cardiac troponin T mutation in familial cardiomyopathy with variable remodeling and restrictive physiology.
Menon SC; Michels VV; Pellikka PA; Ballew JD; Karst ML; Herron KJ; Nelson SM; Rodeheffer RJ; Olson TM
Clin Genet; 2008 Nov; 74(5):445-54. PubMed ID: 18651846
[TBL] [Abstract][Full Text] [Related]
14. Recent progress in the genetics of cardiomyopathy and its role in the clinical evaluation of patients with cardiomyopathy.
Ghosh N; Haddad H
Curr Opin Cardiol; 2011 Mar; 26(2):155-64. PubMed ID: 21297463
[TBL] [Abstract][Full Text] [Related]
15. A novel mutation Lys273Glu in the cardiac troponin T gene shows high degree of penetrance and transition from hypertrophic to dilated cardiomyopathy.
Fujino N; Shimizu M; Ino H; Yamaguchi M; Yasuda T; Nagata M; Konno T; Mabuchi H
Am J Cardiol; 2002 Jan; 89(1):29-33. PubMed ID: 11779518
[TBL] [Abstract][Full Text] [Related]
16. Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy.
Tsoutsman T; Kelly M; Ng DC; Tan JE; Tu E; Lam L; Bogoyevitch MA; Seidman CE; Seidman JG; Semsarian C
Circulation; 2008 Apr; 117(14):1820-31. PubMed ID: 18362229
[TBL] [Abstract][Full Text] [Related]
17. Genetic heterogeneity for autosomal dominant familial hypertrophic cardiomyopathy in a Pakistani family.
Abid A; Akhtar N; Khaliq S; Mehdi SQ
J Coll Physicians Surg Pak; 2011 Apr; 21(4):202-6. PubMed ID: 21453614
[TBL] [Abstract][Full Text] [Related]
18. Coexistence of Digenic Mutations in Both Thin (TPM1) and Thick (MYH7) Filaments of Sarcomeric Genes Leads to Severe Hypertrophic Cardiomyopathy in a South Indian FHCM.
Selvi Rani D; Nallari P; Dhandapany PS; Rani J; Meraj K; Ganesan M; Narasimhan C; Thangaraj K
DNA Cell Biol; 2015 May; 34(5):350-9. PubMed ID: 25607779
[TBL] [Abstract][Full Text] [Related]
19. [Genetics of inherited cardiomyopathies].
Richard P; Fressart V; Charron P; Hainque B
Pathol Biol (Paris); 2010 Oct; 58(5):343-52. PubMed ID: 19942368
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetics of familial hypertrophic cardiomyopathy (FHC).
Bashyam MD; Savithri GR; Kumar MS; Narasimhan C; Nallari P
J Hum Genet; 2003; 48(2):55-64. PubMed ID: 12601548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
